Prevalence and risk factors for chronic oedema in U.K. community nursing services by Moffatt, Christine et al.
Prevalence and Risk Factors for Chronic Edema
in U.K. Community Nursing Services
Christine J. Moffatt, MD, PhD, CBE,1,2,3 Rebecca Gaskin, BA Hons.,4 Martina Sykorova, MA, MRes,5
Eleanor Dring, MSc, BA, RGN,5 Aimee Aubeeluck, PhD, MA, BA,6 Peter J. Franks, PhD, MSc,7
Paul Windrum, PhD, MA,5 Gregoire Mercier, MD, PhD, MSc2
Lorraine Pinnington, PhD, MSc, C Psychol, BA,8 and Isabelle Que´re´, MD, PhD2
Abstract
Background and Study Design: Chronic edema (CO) is believed to be a major clinical problem within
community nursing services in the United Kingdom. This study was undertaken as part of the LIMPRINT
international study to determine the number of people with CO and its impact on health services.
Methods and Results: Three urban-based community nursing services participated in the United Kingdom with
prospective evaluation for 4 weeks of all patients receiving nursing care using a questionnaire-based interview and
clinical assessment using the LIMPRINT tools. Of the total 2541 patients assessed, 1440 (56.7%) were considered
to have CO, comprising Leicester City [768/1298 (59.2%)], Nottingham West [124/181 (68.5%)], and Nottingham
City [548/1062 (51.6%)]. The mean age for women with CO was 78.6 (standard deviation [SD] 12.8) years and
that for men with CO was 72.9 (SD 14.5). More patients with CO suffered from diabetes (32.1% vs. 27.9%,
p= 0.027), heart failure/ischemic heart disease (27.3% vs. 14.0%, p< 0.001), and peripheral arterial occlusive
disease (5.5% vs. 1.9%, p< 0.001). By far the greatest association was with the presence of a wound (73.6% vs.
37.9%, p< 0.001). Cellulitis affected 628 patients (24.7%) and 688 patients (47.8%) had a concurrent leg ulcer.
Rates of reduced mobility (71.6% vs. 61.9%) and obesity were higher in those with CO. Six independent factors
associated with CO were service location, age, ethnicity, obesity, heart failure, and the presence of a wound.
Conclusion: CO is a major and growing health care problem within primary care that has been previously
unrecognized and requires effective service provision.
Keywords: chronic edema, leg ulcer, cellulitis, community nursing services, prevalence, risk factors, lym-
phedema, lymphoedema
Introduction
Chronic edema
Chronic edema (CO) is a major clinical problemworldwide that has many important secondary conse-
quences. The term ‘‘chronic edema’’ is now commonly used
in place of ‘‘lymphedema’’ as this encompasses all forms of
edema that persist for 3 months, irrespective of the etiology
and corresponding comorbidities and risk factors.1 CO is
associated with many long-term conditions such as cancer
and diabetes and is also related to reduced mobility and
obesity, both of which are expected to escalate exponentially
in Western populations for the next 10–15 years.2,3 Although
CO has potentially life-threatening consequences, the prev-
alence and impact of the problem remain poorly understood,
particularly in community care settings.4,5
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To date, the focus of previous research has been to estimate
prevalence in specific patient groups;6 however, since CO is
the final common pathway for many conditions, it is impor-
tant that prevalence is examined among heterogeneous pop-
ulations. One earlier study of a mixed London-based
population estimated the prevalence of CO to be 1.33 per
10001 and more recently a higher level of 3.93 per 1000 in an
urban population in the East Midlands (United Kingdom).4
The context of community nursing
in the United Kingdom
Government policy in the United Kingdom over recent de-
cades has focused on the shift of care from acute hospital ser-
vices to primary care.7 These changes have major implications
for community nursing due to demographic changes of an aging
population. It is estimated that by 2039, the U.K.’s population
will include 3.5 million people aged 85 years and over, with
many over the age of 100 years, which mirrors other Western
countries.8 The rise in the number of elderly patients and im-
proved life expectancy are linked to an increase in the presence
of chronic polymorbidity. It is estimated that by 2018, nearly 3
million people will suffer from three or more coexisting long-
term conditions.9 These changes indicate that the demand for
community nursing will increase over the coming decades.
A review of community nursing by the Queens Nursing
Institute in 2014 highlighted the current challenges in the
United Kingdom.10 They reported that many nurses work in
silos with little access to professional support. Services were
unable to be responsive to sudden changes in demand due to
budgetary restrictions and lack of capacity within existing
teams to extend caseloads when required.
The review also highlighted inconsistent workloads and
inappropriate use of staff skill mix as major factors influencing
the delivery of care. The extent and level of information
technology available to community nursing services were
found to be grossly inadequate, with limited support for im-
plementation and training. The high level of documentation
involved in nursing care created additional pressures for staff
and reduced the time available for patient care.
The recent publication of the framework for nursing,
midwifery, and care staff11 has highlighted the need for a
more integrated health and social care service.
CO and community nursing
Community nurses have been the main provider of care for
leg ulceration and pressure ulcers for many decades and ab-
sorb a large proportion of health resources.12 Reduction in the
incidence of pressure ulceration has been the subject of
government targets with a more recent focus on leg ulceration
and wound assessment (CQUIN program).13
CO has not been recognized as part of a community nursing
remit. The reasons behind this are complex. There is lack of
professional recognition that CO occurs concurrently with ve-
nous ulceration and other wounds.1 In addition, these complex
patients have multiple comorbidities and reduced mobility
placing them at greater risk of CO. However, there is limited
evidence of the size and scope of the problem and more generally
a lack of accurate information about the current patient profile
within community nursing services in the United Kingdom.
A recent wound prevalence study undertaken in two areas
of Nottingham in the United Kingdom showed the prevalence
of CO was low (9%). The reasons for this included a lack of
community nursing knowledge and skills to recognize the
problem and the lack of inclusion in nursing documenta-
tion.14 These underpinning factors informed this study design
that had the following hypotheses:
 Patients with CO would have a high prevalence within
community nursing services
 Patients with leg ulceration would have concurrent CO
 CO would be associated with reduced mobility and obesity
 Patients with CO would have greater comorbidities
than those without
 Cellulitis would be associated with CO.
This study formed part of an international epidemiology
study LIMPRINT to define the prevalence and impact of CO
in health services in different countries and health care sys-
tems. The development and validation of the methods for the
main study are reported separately.15
To understand the current scale of the problem within
community nursing services, the study was designed with two
related aims:
 To estimate the prevalence and impact of CO among a
heterogeneous population within the community nurs-
ing services of three urban geographical areas in the
East Midlands (United Kingdom) and to determine the
proportion that had concurrent leg ulceration.
 To identify risk factors associated with CO.
Materials and Methods
Setting and sampling frame
This cross-sectional study was carried out in three city
locations, Leicester City (population 337,653), Nottingham
City (population 325,000), and Nottingham West (population
112,000). Data were obtained using the same methodology in
each area.
Identification of patients through the creation
of master lists
A master list of all patients in receipt of community nursing
care was generated from the National Health Service (NHS)
systems. The list was divided into the nursing teams
FIG. 1 Study flow of patient screening and entry.
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responsible for their care within each locality. Nursing team
leaders allocated a review of all patients for 4 weeks. Patient
information was provided to all patients by the responsible
community nurse 3 days before the clinical assessment and
consent was obtained from the patient on the day the screening
was undertaken. Clinical review occurred in the normal setting
the patient was seen, this included clinic rooms and the pa-
tient’s own home. The reasons for all exclusion were recorded.
All forms were checked against the master list to ensure
complete data capture.
Screening for CO
People with CO were identified initially by the use of a
standard assessment using the ‘‘Pitting edema Test’’ that
measures the site and depth of swelling in an edematous area
when pressure is applied by the thumb. A positive result is
indicated if a ‘‘pit’’ remains after removal of pressure. This is
a well-established clinical technique, but inter-rater reliabil-
ity was further assessed for its use in the LIMPRINT study.
Levels of agreement were found to be high between general
nurses performing the technique and a clinical expert (gold
standard) in Japan.16 Edema was judged to be chronic if it had
been present for 3 months or more. Participants were also
selected on the basis of the following criteria:
 Adults (>18 years) of both genders
 All ethnic groups
 Receiving community nursing care.
Core data set
A modified core data set was used based on the LIMPRINT
study.15 A detailed classification of primary and secondary
causes of CO was excluded as this lay beyond the skill set of
community nurses. Details of ethnicity, smoking status, and
nursing care requirements were added.
The following data were collected using a standardized
questionnaire:
 social demographics and care: age, gender, ethnicity,
patient’s general practitioner, reason for receiving
community nursing care, frequency of nursing visits;
 presence and site of CO using a body map, details and
duration of CO, cellulitis history, leg ulceration and
wounds, pitting test, stemmer sign, and soft/hard tissues;
 lower limb mobility status (bedbound, chair-bound,
walks with walking aid, walks unaided);
 upper body mobility (full range of movement, limited
range of movement, and normal function);
 obesity status (underweight, normal weight, obese, and
morbidly obese);
 relevant comorbidities: diabetes mellitus, neurological
disorders, heart failure/ischemic heart disease, periph-
eral arterial occlusive disease, and smoking status.
The questionnaire was piloted with five nurses and all
community nurses were trained and assessed as competent by
the research team. An inter-rater reliability study was un-
dertaken to assess community nursing accuracy in detecting
CO after training compared with a gold standard of assess-
ment (Lymphology expert). This was undertaken with 19
patients randomly selected from the main cohort (10 with CO
defined by the community nurse and 9 without). Kappa co-
efficients (>0.85) indicated community nurses were likely to
under predict the presence of CO compared with the expert
assessor. However, there were no false negatives. This indi-
cates that the rates of CO may be slightly lower than the true
prevalence.
Table 1. Total Group Analysis Chronic Edema and Ethnicity in Three City Areas in the United Kingdom
Distribution of CO in patients
treated in the community services
Nottingham City Nottingham West Leicester Total
N % N % N % N %
Chronic edema 548 51.6 124 68.5 768 59.2 1440 56.7
No edema 514 48.4 57 31.5 530 40.8 1101 43.3
Total 1062 181 1298 2541
Ethnicity of all participants
Nottingham City Nottingham West Leicester
TotalN % N % N %
White British/Irish/other White 948 89.6 179 100 982 75.8 2109
Asian/Asian British 36 3.4 0 0 251 19.4 287
Black African/Caribbean/Black British 52 4.9 0 0 36 2.8 88
Other ethnic group 8 0.8 0 0 14 1.1 22
Mixed/multiple ethnic background 14 1.3 0 0 13 1.0 27
Total 1058 179 1296 2533
CO, chronic edema.
FIG. 2. Percentage of community patients with chronic
edema.
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Data collection procedures and approvals
Staff in each community nursing team screened their total
caseloads for consent and inclusion irrespective of the reason
they were receiving nursing care. A unique patient identifi-
cation code was issued to avoid ‘‘double counting’’ for all
cases. Master identifier lists were retained by each service
manager to ensure that anonymity was maintained and for
data protection purposes. Tissue viability specialist services
and managers undertook quality checks and a central project
manager checked data completeness. Approval for the pro-
ject was granted by the Research and Innovation Department
of Leicester and Nottingham, and the trust data protection and
senior management teams in each area.
Data analysis
Data were entered onto an Excel spreadsheet and exported
into Stata 11 where statistical analyses were undertaken. The
analysis was undertaken by examining the differences be-
tween the different city locations. This included comparison
of crude prevalence rates in the patients receiving community
nursing care and the ethnic profiles of each location. The
combined data set was used to examine the associations be-
tween age and gender with the presence of CO. Logistic re-
gression analysis was undertaken to examine the relationship
between the presence of CO and comorbidities including
obesity and poor mobility. Finally, an analysis was under-
taken to identify independent factors that were associated
with the presence of CO in the cohort.
Results
A total of 2636 patients were receiving community nursing
care in the three cities during the study period. Of these 2541
(96.4%) patients consented for inclusion (Fig. 1). Ninety-five
patients were excluded for the following reasons: death (2),
admission to hospital (8), dementia (76), and unwilling to
participate (9). The total number suffering with CO in the
three cities was 1440 of 2541 (56.7%). In Leicester City, 768
of 1298 (59.2%) presented with CO compared with 124 of
181 (68.5%) in Nottingham West and 548 of 1062 (51.6%) in
Nottingham City. Key demographic and clinical data are
presented in Table 1. The mean age for women with CO was
78.6 (standard deviation [SD] = 12.8) years and that for men
with CO was 72.9 (SD = 14.5), which was similar to the
overall population of patients seen by community services
(77.1 and 72.8 years, respectively) (Figure 2). The population
with CO were predominantly white Caucasian but with a
proportion of South Asian descent.
Table 2. Comorbidities
Comorbidities
No edema Chronic edema
OR (95% CI) pN % N %
Diabetes
Absent 794 72.1 978 67.9
Present 307 27.9 462 32.1 1.22 (1.03–1.45) 0.022
Heart failure/CHD
Absent 947 86.0 1047 72.7
Present 154 14.0 393 27.3 2.31 (1.88–2.84) <0.001
Neurological disease
Absent 953 86.6 1258 87.4
Present 148 13.4 182 12.6 0.93 (0.74–1.18) 0.551
Peripheral arterial occlusive disease
Absent 1080 98.1 1361 94.5
Present 21 1.9 79 5.5 2.98 (1.83–4.86) <0.001
Smoking
No 470 91.4 481 87.8
Yes 44 8.6 67 12.2 1.49 (0.99–2.22) 0.051
Wound present
Absent 682 62.1 380 26.4 1.00
Present 417 37.9 1059 73.6 4.56 (3.85–5.40) <0.001
CHD, chronic heart failure; CI, confidence interval; OR, odds ratio.
Table 3. Cellulitis in Patients
with Chronic Edema
Cellulitis history N Total %
Ever had cellulitis
Yes 628 2534 24.7
Infection in past year 411 2123 16.2
Number of infections
0 2069 83.5
1 224 9.04
2 88 3.55
3 49 1.98
4 26 1.05
5 10 0.40
>5 11 0.40
Hospitalization
0 2429 97.94
1 38 1.53
2 11 0.44
3–4 2 0.08
Repeat antibiotics 402 2468 16.29
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Comorbidities were common with more patients with
CO also suffering from diabetes (32.1% vs. 27.9%, p = 0.027)
and heart failure/ischemic heart disease (27.3% vs. 14.0%,
p < 0.001), Table 2. Peripheral arterial occlusive disease was
more frequent in the CO group (5.5% vs. 1.9%, p < 0.001). By
far the greatest association was with the presence of a wound
(73.6% vs. 37.9%, p < 0.001).
A history of cellulitis was reported as a common complication
affecting 628 patients (24.7%), of whom 411 (16.2%) were re-
ported in the last year (Table 3). Although 224 (9%) reported
only one episode, 11 had suffered >5. Of the total experiencing
cellulitis, 49 patients had required hospitalization for intravenous
antibiotics during the last year and a further 402 patients (16.2%)
were receiving repeat prescriptions for antibiotics. Wounds oc-
curred concurrently with CO in 73.6% of cases. Of the total with
CO, 28.4% could walk unaided compared with 38% in those
without CO. Obesity and morbid obesity occurred in 34.9% of
those with CO compared with 13.5% in those unaffected.
Less than a third (29.2%) were receiving nursing care once
a week with >40% requiring twice weekly visits and 13.7%
requiring daily visits (Table 4). A further 32 (2.4%) patients
required twice or three times daily visits including the night
Table 4. Frequency and Site of Provision of Community Nursing Care
Community nursing care
No edema Chronic edema
OR (95% CI) pN % N %
Place
Clinic 98 8.9 244 17.0 1.00
Home 1003 91.1 1194 83.0 0.48 (0.37–0.61) <0.001
Visits per week
Once per week 310 32.6 398 29.2 1.00
Twice per week 251 26.4 560 41.2 1.74 (1.41–2.14)
More than 2/week 124 13.0 184 13.5 1.16 (0.88–1.52) <0.001
Once per day 238 25.0 187 13.7 0.61 (0.48–0.78)
More than once per day 29 3.1 32 2.4 0.86 (0.51–1.45)
Table 5. Factors Associated with Chronic Edema (Univariate Analysis)
Factors associated with
the presence of CO
No edema Chronic edema
OR (95% CI) pN % N %
Gender
male 496 45.1 598 41.5 1.00
female 604 54.9 842 58.5 1.15 (0.99–1.35) 0.072
Age (years)
<30 24 2.2 10 0.7 1.00
30–39 31 2.8 13 0.9 1.01 (0.38–2.69)
40–49 59 5.4 48 3.3 1.95 (0.85–4.48)
50–59 98 8.9 116 8.1 2.84 (1.30–6.23) <0.001
60–69 150 13.7 186 12.9 2.98 (1.38–6.42)
70–79 191 17.4 356 24.7 4.47 (2.10–9.55)
80–89 379 34.5 522 36.3 3.31 (1.56–6.99)
90+ 166 15.1 189 13.1 2.73 (1.27–5.88)
Ethnicity
White 851 77.8 1258 87.4 1.00
Asian 161 14.7 127 8.8 0.53 (0.42–0.68)
Black 53 4.8 35 2.4 0.45 (0.29–0.69) <0.001
Other 12 1.1 10 0.7 0.56 (0.24–1.31)
Mixed 17 1.6 10 0.7 0.40 (0.18–0.57)
Obesity
Underweight 199 18.1 132 9.2 1.00
Normal weight 752 68.4 805 55.9 1.61 (1.27–2.05)
Obese 135 12.3 408 28.3 4.55 (3.39–6.11) <0.001
Morbidly obese 13 1.2 95 6.6 11.01 (5.93–20.48)
Lower limb mobility
Walks unaided 418 38.1 409 28.4 1.00
Walks with aid 440 40.1 760 52.8 1.77 (1.47–2.11)
Chair bound 137 12.5 181 12.6 1.35 (1.04–1.75) <0.001
Bed bound 103 9.4 89 6.2 0.88 (0.64–1.21)
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service. Most patients were receiving care at home (83%)
with a small proportion (17%) attending a clinic for treat-
ment. These results are somewhat different from those of the
patients with no edema, who were seen more frequently than
the patients with edema. This is probably due to the serious
underlying conditions that required care.
Univariate analysis identified a number of factors associ-
ated with an increased risk of having CO, these are presented
in Table 5. Diabetes mellitus, heart failure, peripheral arterial
occlusive disease, the presence of a wound or leg ulcer, and
frequency of treatment were all identified. These factors were
entered in a multivariate model that confirmed the following
six independent risk factors: city location of the service, in-
creased age, ethnicity (white Caucasian), obesity and morbid
obesity, heart failure/ischaemic heart disease, and the pres-
ence of a wound (Table 6).
Discussion
Results from this study support the first study hypothesis
that the prevalence of CO in patients treated by community
nurses is high and has a significant association with the
population of patients with wounds. As predicted, there is a
relationship with age that has been identified in other studies;
however, in this population, the distribution of gender was
different with more males affected than in other research
within similar populations.1,17
Community nursing services are delivering care to some of
the most unwell and frail patients within the NHS. The cri-
terion for a home visit is that the patient is unable to reach a
clinic and this is reflected in this study with >80% being seen
at home. However, the results indicate that CO adds an ad-
ditional burden that further reduces mobility compared with
those who are unaffected, and that obesity and morbid obesity
are more problematic in this patient population. This is a
population with many coexisting conditions and risk factors
that may play an important role in the mechanisms leading
to CO.
The role of ethnicity has not been examined in previous
studies of CO patients. In this study, the pattern of ethnicity did
not reflect the ethnic distribution within the general population.
The sample was largely white Caucasian with few patients
from Africa or south Asia despite in Leicester >60% of the
general population being from these ethnic minority groups. It
is not possible to determine whether this indicates that these
patients are not accessing community nursing care or whether
ethnicity directly influences the prevalence of CO.
Within the primary LIMPRINT study, the acute hospital
prevalence of Japan was very low (6%) compared with a
prevalence in European populations.18 This may indicate the
importance of factors such as obesity. However, in elderly
care hospitals in Japan, the prevalence was >60%, indicating
the link with increasing age and comorbidities.19 Previous
research in leg ulceration found a similar population profile in
an area of London with a high South Asian population.20 The
role of ethnicity in CO requires further elucidation to un-
derstand its potential importance.
The study indicates that CO is not being effectively
managed within primary care in the United Kingdom with
patients requiring frequent nursing visits. The overall rate of
cellulitis in this study (24.7%) is similar to that reported in
the results from LIMPRINT (34%) study. Detection and
correct classification of cellulitis are often difficult and
will be influenced by the level of skill clinical staff hold
locally in assessment and treatment. Cellulitis may be
confused with a number of other conditions such as contact
dermatitis, chronic lipodermatosclerosis, acute inflamma-
tory episodes, and acute erythema from uncontrolled ede-
ma.21 The high prescription rate of repeat antibiotics
indicates that this is an important clinical issue that must be
addressed and is compounded by the high number of con-
current wounds.
The main limitation of this study is the inability to de-
termine whether patients have a primary or secondary CO.
Primary forms are due to developmental abnormalities in
the lymphatic system, some of which are due to genetic
causes.22 Secondary CO occurs due to damage to the
lymphatic and venous system and is compounded by issues
such as immobility and obesity. There is, however, in-
creasing recognition that even in primary forms of lym-
phedema, lymphatic and venous abnormalities may
coexist. The common pathway to the development of CO is
complex and influenced by episodes of infection that fur-
ther damage the lymphatic transport and the development
of adipose tissue.
In addition, the use of polypharmacy is implicated in
edema formation. Many drugs are associated with edema
Table 6. Independent Risk Factors Associated
with Chronic Edema (Multivariable Analysis)
Independent risk factors OR (95% CI) p
Site
Site A 1.00
Site B 1.54 (1.04–2.27) 0.024
Site C 1.35 (1.11–1.64)
Age (years)
<30 1.00
30–39 1.14 (0.39–3.32)
40–49 1.82 (0.73–4.54)
50–59 2.58 (1.08–6.13) <0.001
60–69 2.94 (1.26–6.86)
70–79 5.24 (2.27–12.14)
80–89 4.49 (1.90–10.31)
90+ 3.78 (1.62–8.85)
Ethnicity
White 1.00
Asian 0.53 (0.40–0.71)
Black 0.66 (0.41–1.07) <0.001
Other 0.53 (0.19–1.48)
Mixed 0.56 (0.23–1.36)
Obesity
Underweight 1.00
Normal weight 1.64 (1.26–2.15)
Obese 4.78 (3.45–6.64) <0.001
Morbidly obese 10.34 (5.28–20.22)
Heart failure/CHD
Absent 1.00
Present 1.90 (1.50–2.40) <0.001
Wound
Absent 1.00
Present 4.49 (3.72–5.39) <0.001
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such as calcium channel blockers used for hypertension and
corticosteroids used for inflammatory conditions. Cancer
drugs such as the taxanes are known to increase edema as are
neuroleptic medications.23 The true mechanisms that lead to
CO in this heterogeneous population require further study.
However, based on our current understanding, the main
treatment for all types of CO irrespective of the underlying
etiology requires appropriate compression and this is influ-
enced by factors such as limb shape, tissue changes, and
overall function, which are profoundly altered in such patients.
The magnitude of the number of patients with CO in this
study highlights the need for a rapid improvement in services
that link acute and primary care. Initial studies in the United
Kingdom indicate that integrated services with access to
specialist advice can provide cost-effective outcomes and
improved quality of life.17 The financial burden of managing
patients with a wound was assessed during 2012–2013 and
estimated at £2.2 million with 66% of the financial burden
falling to community nursing services and general practi-
tioners.24 The main cost of £1.94 million was attributed to leg
ulcers (projected number 731,000 ulcers). When factoring the
cost of comorbidities for this group, the cost increased to 5.3
billion or 4% of the public health expenditure at the time.
This is similar in magnitude to the treatment of obesity.
Despite this, 39% (0.9 million wounds) remained unhealed
with the cost per patient ranging from £1719 to £5976. The
costs drivers were related to nonhealing and the presence of
diabetes and nutritional deficiency. Wound management is
predominantly a nurse-led discipline but an estimated 30% of
wounds lacked a correct diagnosis and compression was used
in less than half. The study identified lack of access to spe-
cialist nurses as important issues affecting outcome and
influencing costs. The results from this study support the
magnitude of the problem and indicate that uncontrolled CO
is an important factor contributing to poor wound healing.
The use of prospective evaluation of all patients in this study
rather than use of data from a primary care database wound
indicate that the problem may be even greater than previously
predicted.
Conclusions
This study found that between 52% and 69% of patients
cared for by community nurses have CO and of these 73%
have a concurrent leg ulcer in the United Kingdom. Both
clinical problems require effective compression therapy.
Risk factor analysis has shown the importance of an in-
creasingly aging and obese population with important
comorbidities such as diabetes mellitus, heart failure, and
reduced mobility. The projected changes in Western
populations would indicate that CO is an important and
expanding public health issue that must be urgently ad-
dressed.
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